Harmony Biosciences Holdings IncNASDAQ:HRMY
- LAST PRICE29.1900
- TODAY'S CHANGE (%)-0.5900 (-1.9812%)
- Bid / Lots24.4400/ 1
- Ask / Lots29.9500/ 5
- Open / Previous Close30.0700 / 29.7800
- Day Range
- 52 Week Range
- Volume364,005
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HRMY |
|---|---|---|
| 09:32 ET | 4276 | 30.07 |
| 09:34 ET | 1140 | 29.93 |
| 09:38 ET | 250 | 30 |
| 09:41 ET | 275 | 29.895 |
| 09:48 ET | 100 | 30 |
| 09:50 ET | 500 | 29.975 |
| 09:54 ET | 1895 | 29.675 |
| 09:56 ET | 100 | 29.66 |
| 09:59 ET | 300 | 29.525 |
| 10:06 ET | 200 | 29.475 |
| 10:08 ET | 400 | 29.325 |
| 10:10 ET | 1241 | 29.36 |
| 10:12 ET | 2400 | 29.335 |
| 10:14 ET | 100 | 29.345 |
| 10:15 ET | 3028 | 29.46 |
| 10:17 ET | 400 | 29.47 |
| 10:21 ET | 100 | 29.465 |
| 10:24 ET | 300 | 29.465 |
| 10:26 ET | 100 | 29.42 |
| 10:28 ET | 1970 | 29.48 |
| 10:32 ET | 1400 | 29.51 |
| 10:33 ET | 200 | 29.5 |
| 10:35 ET | 107 | 29.523 |
| 10:37 ET | 2395 | 29.58 |
| 10:39 ET | 7925 | 29.65 |
| 10:44 ET | 179 | 29.6552 |
| 10:46 ET | 1758 | 29.66 |
| 10:50 ET | 100 | 29.7 |
| 10:51 ET | 400 | 29.65 |
| 10:53 ET | 300 | 29.66 |
| 10:55 ET | 300 | 29.645 |
| 10:57 ET | 250 | 29.635 |
| 11:00 ET | 100 | 29.595 |
| 11:02 ET | 200 | 29.67 |
| 11:04 ET | 100 | 29.7 |
| 11:06 ET | 2025 | 29.775 |
| 11:11 ET | 100 | 29.775 |
| 11:13 ET | 300 | 29.795 |
| 11:18 ET | 1200 | 29.77 |
| 11:20 ET | 315 | 29.755 |
| 11:22 ET | 100 | 29.755 |
| 11:24 ET | 200 | 29.78 |
| 11:26 ET | 100 | 29.78 |
| 11:27 ET | 556 | 29.75 |
| 11:29 ET | 600 | 29.73 |
| 11:31 ET | 815 | 29.63 |
| 11:33 ET | 100 | 29.59 |
| 11:36 ET | 900 | 29.67 |
| 11:38 ET | 100 | 29.64 |
| 11:40 ET | 100 | 29.595 |
| 11:42 ET | 400 | 29.655 |
| 11:44 ET | 888 | 29.7288 |
| 11:45 ET | 200 | 29.73 |
| 11:47 ET | 100 | 29.74 |
| 11:49 ET | 800 | 29.77 |
| 11:51 ET | 500 | 29.73 |
| 11:54 ET | 100 | 29.72 |
| 11:56 ET | 300 | 29.75 |
| 12:00 ET | 100 | 29.78 |
| 12:02 ET | 300 | 29.77 |
| 12:03 ET | 729 | 29.68 |
| 12:05 ET | 1300 | 29.6 |
| 12:07 ET | 1075 | 29.61 |
| 12:09 ET | 2104 | 29.62 |
| 12:12 ET | 100 | 29.71 |
| 12:16 ET | 100 | 29.73 |
| 12:18 ET | 500 | 29.75 |
| 12:21 ET | 300 | 29.83 |
| 12:23 ET | 100 | 29.82 |
| 12:25 ET | 200 | 29.83 |
| 12:27 ET | 200 | 29.815 |
| 12:32 ET | 200 | 29.8 |
| 12:34 ET | 100 | 29.76 |
| 12:38 ET | 100 | 29.81 |
| 12:39 ET | 612 | 29.77 |
| 12:41 ET | 100 | 29.73 |
| 12:45 ET | 100 | 29.71 |
| 12:48 ET | 100 | 29.7 |
| 12:50 ET | 100 | 29.75 |
| 12:52 ET | 1100 | 29.715 |
| 12:54 ET | 100 | 29.68 |
| 01:01 ET | 232 | 29.69 |
| 01:06 ET | 300 | 29.8 |
| 01:08 ET | 400 | 29.815 |
| 01:14 ET | 314 | 29.813 |
| 01:15 ET | 543 | 29.83 |
| 01:17 ET | 1725 | 29.825 |
| 01:19 ET | 100 | 29.85 |
| 01:21 ET | 1500 | 29.865 |
| 01:30 ET | 100 | 29.87 |
| 01:32 ET | 5494 | 29.74 |
| 01:33 ET | 949 | 29.71 |
| 01:35 ET | 700 | 29.61 |
| 01:37 ET | 800 | 29.65 |
| 01:39 ET | 4503 | 29.6 |
| 01:42 ET | 100 | 29.56 |
| 01:44 ET | 358 | 29.56 |
| 01:46 ET | 720 | 29.57 |
| 01:48 ET | 100 | 29.54 |
| 01:50 ET | 1300 | 29.6 |
| 01:51 ET | 1110 | 29.55 |
| 01:53 ET | 2100 | 29.6 |
| 01:55 ET | 400 | 29.6 |
| 01:57 ET | 787 | 29.56 |
| 02:00 ET | 300 | 29.58 |
| 02:02 ET | 500 | 29.57 |
| 02:04 ET | 100 | 29.585 |
| 02:06 ET | 500 | 29.57 |
| 02:08 ET | 300 | 29.53 |
| 02:09 ET | 905 | 29.52 |
| 02:11 ET | 1700 | 29.535 |
| 02:13 ET | 100 | 29.56 |
| 02:15 ET | 627 | 29.52 |
| 02:18 ET | 700 | 29.4 |
| 02:24 ET | 300 | 29.39 |
| 02:26 ET | 700 | 29.465 |
| 02:27 ET | 300 | 29.42 |
| 02:29 ET | 200 | 29.465 |
| 02:31 ET | 148 | 29.45 |
| 02:36 ET | 4100 | 29.3518 |
| 02:38 ET | 1200 | 29.45 |
| 02:40 ET | 531 | 29.445 |
| 02:42 ET | 1000 | 29.475 |
| 02:44 ET | 500 | 29.515 |
| 02:45 ET | 200 | 29.58 |
| 02:47 ET | 1700 | 29.575 |
| 02:49 ET | 536 | 29.55 |
| 02:51 ET | 995 | 29.6 |
| 02:54 ET | 2564 | 29.475 |
| 02:56 ET | 600 | 29.39 |
| 02:58 ET | 100 | 29.405 |
| 03:00 ET | 599 | 29.39 |
| 03:02 ET | 200 | 29.34 |
| 03:03 ET | 416 | 29.31 |
| 03:05 ET | 2093 | 29.23 |
| 03:07 ET | 600 | 29.195 |
| 03:09 ET | 600 | 29.19 |
| 03:12 ET | 1451 | 29.155 |
| 03:14 ET | 500 | 29.17 |
| 03:16 ET | 600 | 29.17 |
| 03:18 ET | 100 | 29.195 |
| 03:20 ET | 200 | 29.195 |
| 03:21 ET | 200 | 29.185 |
| 03:23 ET | 1900 | 29.24 |
| 03:25 ET | 400 | 29.27 |
| 03:27 ET | 730 | 29.3 |
| 03:30 ET | 1509 | 29.3 |
| 03:32 ET | 583 | 29.275 |
| 03:34 ET | 598 | 29.28 |
| 03:36 ET | 728 | 29.28 |
| 03:38 ET | 1113 | 29.2 |
| 03:39 ET | 1150 | 29.17 |
| 03:41 ET | 2118 | 29.225 |
| 03:43 ET | 100 | 29.225 |
| 03:45 ET | 300 | 29.225 |
| 03:48 ET | 1100 | 29.28 |
| 03:50 ET | 2145 | 29.285 |
| 03:52 ET | 4956 | 29.21 |
| 03:54 ET | 3803 | 29.22 |
| 03:56 ET | 2455 | 29.24 |
| 03:57 ET | 3913 | 29.25 |
| 03:59 ET | 3924 | 29.19 |
Yesterday
HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024, from 8:05AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:05AM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 12, 2024
DJ Harmony Biosciences Price Target Maintained With a $49.00/Share by Cantor Fitzgerald, from 10:03AM ET on Friday Apr 12, 2024 by Dow Jones
10:03AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 11, 2024
DJ Harmony Biosciences Price Target Maintained With a $50.00/Share by Needham, from 1:34PM ET on Thursday Apr 11, 2024 by Dow Jones
1:34PM ET on Thursday Apr 11, 2024 by Dow JonesHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST, from 8:05AM ET on Thursday Apr 11, 2024 by Dow Jones
8:05AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 9, 2024
DJ Harmony Biosciences Price Target Maintained With a $50.00/Share by Needham, from 6:34AM ET on Tuesday Apr 09, 2024 by Dow Jones
6:34AM ET on Tuesday Apr 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Harmony Biosciences Holdings Inc | 1.7B | 13.7x | --- |
Taro Pharmaceutical Industries Ltd | 1.6B | 34.7x | -33.66% |
Tilray Brands Inc | 1.4B | -3.5x | --- |
Collegium Pharmaceutical Inc | 1.2B | 40.2x | --- |
Amphastar Pharmaceuticals Inc | 2.0B | 15.5x | --- |
ANI Pharmaceuticals Inc | 1.4B | 79.8x | -8.16% |
Company Information
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action (MOA) designed to enhance histamine signaling in the brain by binding to H3 receptors. Its WAKIX is developed for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy and treatment of cataplexy in adult patients with narcolepsy. Its narcolepsy treatment works primarily through histamine, a wake-promoting neurotransmitter. It also provides HBS-102, an investigational compound, which is a melanin-concentrating hormone (MCH) receptor 1 (MCHR1) antagonist that targets MCH neurons in the brain. It also develops ZYN002, a pharmaceutically manufactured synthetic cannabidiol.
Contact Information
- Headquarters
- 630 W Germantown Pike, Suite 215PLYMOUTH MEETING, PA, United States 19462
- Phone
- 484-539-9800
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Jeffrey Aronin
- Interim President and Chief Executive Officer, Chief Medical Officer
- Jeffrey Dayno
- Chief Financial Officer, Chief Administrative Officer
- Sandip Kapadia
- Chief Commercial Officer
- Jeffrey Dierks
- Chief Strategy Officer
- Andrew Serafin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
|---|---|
Revenue (TTM) | $582.0M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.76 |
EPS | $2.13 |
Book Value | $8.23 |
P/E Ratio | 13.7x |
Price/Sales (TTM) | 2.9 |
Price/Cash Flow (TTM) | 11.0x |
Operating Margin | 31.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
